People · Operator
Named in public records as an officer, director or promoter · active 2013–2024 · Biotechnology, Pharmaceuticals, Other, Agriculture
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Applied Therapeutics Inc. | — | Biotechnology | Series C | $189.2M | $1.0B | 2018 |
| Intra Cellular Therapies Inc | — | Pharmaceuticals | Series C | $80.9M | $2.1B | 2013 |
| AltPep Corp | — | Biotechnology | Series C | $69.6M | $837.9M | 2022 |
| Equilibre BioPharmaceuticals Corp. | — | Pharmaceuticals | Series B | $47.7M | $79.7M | 2020 |
| Boragen, Inc. | — | Other | Series B | $43.0M | $32.1M | 2017 |
| TRex Holdings Inc. | — | Biotechnology | Series C | $42.3M | $329.3M | 2024 |
| Rodeo Therapeutics Corp | — | Biotechnology | Series A | $14.3M | $323.6M | 2017 |
| ApoGen Biotechnologies, Inc. | — | Biotechnology | Series A | $7.6M | $273.5M | 2016 |
| Vindara, Inc. | — | Agriculture | Seed | $4.2M | $20.4M | 2018 |
Joel Marcus at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Joel Marcus on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Asish Xavier | 2 | 18 |
| Steve Gillis | 2 | 13 |
| Thong Le | 2 | 12 |
| James Sullivan | 2 | 7 |
| Lindsay Rayle | 2 | 7 |
| David Schubert | 2 | 6 |
| Roger Kemble | 2 | 4 |
| John Dombrosky | 2 | 3 |
| Tracy Jackson | 2 | 2 |
| Michael Ross | 1 | 18 |
| Kristina Burow | 1 | 16 |
| David Friedman | 1 | 9 |
| Alexandra Cantley | 1 | 8 |
| Franklin Berger | 1 | 7 |
| Peter Hirth | 1 | 7 |
| Peter Simon | 1 | 6 |
| Carol Gallagher | 1 | 6 |
| M. Johnston Erwin | 1 | 5 |
| John Santini | 1 | 5 |
| Chad Robins | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.